AN ADEQUATELY FUNCTIONING vascular access is an absolute requisite for patients receiving hemodialysis. Among the three currently available (fistulae, grafts, and tunneled catheters) vascular accesses, the arteriovenous fistula (AVF) is considered the "gold standard" and is the most common mode of vascular access (9, 16) . AVF has several advantages that include lower risk of infections and clot formation, better blood flow, and hence superior effectiveness of dialysis and higher longevity compared with other vascular access modalities (16) . Nevertheless, the rates of inadequate AVF maturation and functional failure are alarmingly high (16) . Such failure rates translate to significant morbidity, hospitalization, and mortality. Furthermore, the yearly health care costs for vascular access-related morbidity are well over one billion dollars in the United States alone (2, 11) . The number of patients requiring hemodialysis has increased remarkably in the past few decades. Therefore, there is an urgent need to study the underlying mechanisms of AVF dysfunction to enable implementation of novel preventive and therapeutic strategies to improve quality of care in hemodialysis patients.
The major cause of AVF failure is either unsuccessful maturation or venous stenosis of a matured AVF. Although several mechanisms have been proposed for AVF malfunction, venous stenosis resulting from neointimal hyperplasia within the perianastomotic region is undoubtedly the most common cause of AVF failure in hemodialysis patients. Despite the magnitude of this clinical challenge, there are no effective preventive and/or therapeutic measures to adequately address this condition. In an attempt to decipher the pathobiological pathways that lead to AVF venous stenosis and AVF failure, animal models have been designed that closely mimic the human lesion and hemodynamic features (1, 5, 7) . These studies demonstrate that the venous stenosis is associated with several pathological characteristics such as smooth muscle cell migration and proliferation, monocyte/macrophage infiltration, fibrosis, and microangiogenesis that may be accompanied by thrombosis and/or calcification and upregulation of a number of inflammatory genes (10 -12) .
While a strong body of evidence suggests that disproportionate reactive oxygen species, in particular superoxide anions, are involved in the pathogenesis of a number of vascular injury and remodeling conditions (3, 4, 13) , whether such derangements could account for the AVF failure has not been comprehensively explored. In an issue of the American Journal of Physiology-Renal Physiology, Tsapenko and colleagues (15) investigated the pathogenic role of superoxide anion in venous stenosis in a rat model of femoral AVF. The authors report significant augmentation of superoxide anion levels at one week postcreation of the AVF in the venous limb. Such increment was attributed to both increased generation and decreased dismutation of the superoxide anions due to reduced total superoxide dismutase expression and activity. Superoxide dismutase is an antioxidant enzyme that converts two superoxide anions into a molecule of hydrogen peroxide (decomposed and neutralized by glutathione peroxidase and catalase) and one molecule of oxygen. This concept was further validated by either unchanged or increased levels of glutathione peroxidase and catalase, respectively. Interestingly, the authors also report evidence of significant tyrosine nitration in all three layers of the veins as well as infiltrating leukocytes in the AVF. This observation highlights the increased generation of peroxynitrite, a product of superoxide anion interaction with nitrogen oxide. Under a number of pathological conditions, nitric oxide synthase (NOS) activity becomes uncoupled, leading to increased production of superoxide anion. Indeed, NOS uncoupling has been implicated in vasculopathies such as atherosclerosis. To validate evidence of such uncoupling, the authors demonstrate that the tetrahydrobiopterin (BH 4 )-to-dihydrobiopterin (BH 2 ) ratio (a reliable marker of NOS uncoupling) is significantly reduced in the venous segment of the AVF.
To elucidate other downstream effects of increased superoxide anion generation, several potential candidate pathways were investigated. Intriguingly, only Src and its phosphory-lated form were markedly elevated. Because Src is involved both up-and downstream of superoxide anion, these results suggest a vicious cycle of superoxide anion generation and positive feedback that further instigates the cycle. Moreover, the significance and the potential of mitigating the markedly increased superoxide anions as a therapeutic target were also elegantly deciphered. Administration of tempol, a well-known membrane-permeable radical scavenger with potent antioxidant properties, significantly improved the histological changes, AVF patency, and, at higher doses, also augmented blood flow through the AVF.
The findings by Tsapenko and colleagues elaborately describe the role of oxidative stress in AVF dysfunction. This increase in oxidative stress, as a result of augmented superoxide anion, induces the antioxidant enzyme heme oxygenase-1 (HO-1) . HO-1 catalyzes the breakdown of heme into equimolar quantities of iron, carbon monoxide, and biliverdin (14) . Biliverdin is further reduced to bilirubin by biliverdin reductase. Both bile pigments are capable of scavenging peroxy radicals while carbon monoxide can induce vasodilation. Therefore, HO-1 induction, as an adaptive response to injury, is critical for protection against AVF dysfunction. In fact, a previous study from the laboratory of Juncos et al. demonstrated the induction of HO-1 in a murine model of AVF (6) . The beneficial significance of such induction was highlighted by premature failure of AVF in HO-1 Ϫ/Ϫ mice (6). Furthermore, these results are corroborated in patients with HO-1 gene polymorphisms [dinucleotide GT repeat (GT)(n) in the promoter region] (8). The longer-length GT repeats are associated with decreased HO-1 expression and a higher propensity of AVF access failure and worse patency (8) .
In summary, the findings by Tsapenko and colleagues (15) provide a novel pathological link between superoxide, Src activation, and AVF patency (Fig. 1) . They provide biochemical evidence for the role of BH 4 and BH 2 in the uncoupling of NOS that results in increased generation of superoxide anion and that scavenging of superoxide with tempol improved AVF dysfunction. They also provide a link between Src kinase and aggravation of oxidative stress, leading to intimal hyperplasia and AVF failure. This study will certainly stimulate further research into the development of novel therapeutics to target key signaling pathways demonstrated in this study to prevent AVF dysfunction and improve AVF patency. Given the presence of heightened oxidative stress and inflammation in endstage renal disease, these redox pathways would be relevant to target to prolong the lifespan of vascular access in dialysis patients.
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